| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.3 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |